Litcius/Paper detail

Targeting HER2 in Breast Cancer: Latest Developments on Treatment Sequencing and the Introduction of Biosimilars

Megan E. Tesch, Karen A. Gelmon

2020Drugs43 citationsDOI

Topics & Concepts

TrastuzumabPertuzumabLapatinibMedicineBiosimilarNeratinibTrastuzumab emtansineMetastatic breast cancerBreast cancerOncologyTargeted therapyInternal medicineCancerPharmacologyHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchBiosimilars and Bioanalytical Methods
Targeting HER2 in Breast Cancer: Latest Developments on Treatment Sequencing and the Introduction of Biosimilars | Litcius